id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
VA-2020-VHA-0023-0023,VA,VA-2020-VHA-0023,AQ31-Final Rule-Impact Analysis-Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists,Supporting & Related Material,,2021-09-20T04:00:00Z,2021,9,,,2021-09-22T12:31:41Z,,0,0,0900006484d966c1
VA-2020-VHA-0023-0022,VA,VA-2020-VHA-0023,AQ31-Final Rule-Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists,Rule,,2021-09-20T04:00:00Z,2021,9,,,2021-09-21T00:59:27Z,2021-20196,0,0,0900006484d939e5
VA-2020-VHA-0023-0001,VA,VA-2020-VHA-0023,AQ31-Proposed Rule - Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists,Proposed Rule,,2020-11-06T05:00:00Z,2020,11,2020-11-06T05:00:00Z,2021-01-06T04:59:59Z,2021-01-06T02:02:35Z,2020-24370,0,0,090000648494df41
VA-2020-VHA-0023-0002,VA,VA-2020-VHA-0023,AQ31(P) Impact Analysis - Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists,Supporting & Related Material,,2020-11-06T05:00:00Z,2020,11,,,2020-11-09T12:57:20Z,,0,0,0900006484950c59